Related references
Note: Only part of the references are listed.High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women
R. Donken et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women
Marette H. Lee et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2018)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
Kimberley Kavanagh et al.
LANCET INFECTIOUS DISEASES (2017)
Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study
M. E. Cruickshank et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study
A. Munro et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2017)
Impact of 2-, 4-and 9-valent HPV vaccines on morbidity and mortality from cervical cancer
Rebecca Luckett et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
HPV immunisation and cervical screening-confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
T. J. Palmer et al.
BRITISH JOURNAL OF CANCER (2016)
HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data
T. J. Palmer et al.
BRITISH JOURNAL OF CANCER (2016)
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Suzanne M. Garland et al.
CLINICAL INFECTIOUS DISEASES (2016)
Use of HPV testing for cervical screening in vaccinated womenInsights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study
Ramya Bhatia et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Eva Herweijer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Need for expanded HPV genotyping for cervical screening
Jack Cuzick et al.
PAPILLOMAVIRUS RESEARCH (2016)
The Early Benefits of Human Papillomavirus Vaccination on Cervical Dysplasia and Anogenital Warts
Leah M. Smith et al.
PEDIATRICS (2015)
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation
David Mesher et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Monitoring Effect of Human Papillomavirus,Vaccines in US Population, Emerging Infections Program, 2008-2012
Susan Hariri et al.
EMERGING INFECTIOUS DISEASES (2015)
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
K. Kavanagh et al.
BRITISH JOURNAL OF CANCER (2014)
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
K. G. J. Pollock et al.
BRITISH JOURNAL OF CANCER (2014)
Achieving high and equitable coverage of adolescent HPV vaccine in Scotland
Katy Sinka et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2014)
Early Impact of Human Papillomavirus Vaccination on Cervical NeoplasiauNationwide Follow-up of Young Danish Women
Birgitte Baldur-Felskov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
Kimberley Kavanagh et al.
BMC INFECTIOUS DISEASES (2013)
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Dorota M. Gertig et al.
BMC MEDICINE (2013)
Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008-2011
Linda M. Niccolai et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)
Catherine H. Mercer et al.
LANCET (2013)
Evaluation of Type-Specific HPV Persistence and High-Risk HPV Viral Load Quantitation in HPV Positive Women Under 30 With Normal Cervical Cytology
Xavier Carcopino et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
Julia M. L. Brotherton et al.
LANCET (2011)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
The proposed BSCC terminology for abnormal cervical cytology
Karin Denton
CYTOPATHOLOGY (2008)
CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples
Joseph D. Carreon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Share Paper
